Aristides Capital LLC Immatics N.V. Transaction History
Aristides Capital LLC
- $260 Million
- Q4 2024
A detailed history of Aristides Capital LLC transactions in Immatics N.V. stock. As of the latest transaction made, Aristides Capital LLC holds 28,900 shares of IMTX stock, worth $145,945. This represents 0.08% of its overall portfolio holdings.
Number of Shares
28,900Holding current value
$145,945% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding IMTX
# of Institutions
93Shares Held
91.7MCall Options Held
313KPut Options Held
377K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.6MShares$53.6 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA10.4MShares$52.6 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$47.4 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$36.7 Million0.57% of portfolio
-
Rtw Investments, LP New York, NY6.54MShares$33 Million0.76% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $385M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...